📰 Temporary Rule News
Temporary Rule News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Temporary Rule. Real-time updates on events, politics, business and more.
October 25, 2023
The October 2023 issue of Greenberg Traurig's quarterly Behavioral Health Law Ledger discusses the new federal fraud and abuse allowances for physician mental health and wellness programs...
October 24, 2023
On October 10, 2023, the federal Drug Enforcement Administration (DEA) issued another extension (Second Temporary Rule) of its pandemic-era telehealth flexibilities “in light of the...
October 16, 2023
On October 6, 2023, the Drug Enforcement Agency (DEA) and the Department of Health and Human Services (HHS) issued a Second Temporary Rule further extending the ability to prescribe...
October 10, 2023
On October 6, 2023, the Drug Enforcement Administration (DEA) released a second temporary rule extending the COVID-19 Telemedicine Flexibilities for Prescription of Controlled...
October 5, 2023
The new interim rule follows the first detection of CRB on Maui three weeks ago, when a dead adult CRB was found in a bag of compost shipped from O‘ahu at a Maui retailer. No other CRB has been detected on Maui. However, the efforts to restore the land and soil on Maui and Hawai‘i Island due to the wildfire damage have increased shipments of compost and organic landscaping material from O‘ahu, increasing the risk of the transport of CRB to non-infested areas.
July 31, 2023
On July 21, 2023, the U.S. Department of Homeland Security ("DHS") announced multiple changes to the Form I-9 process.
June 14, 2023
DEA granted temporary exceptions under the Ryan Haight Online Pharmacy Consumer Protection Act allowing healthcare providers to prescribe controlled medications via telemedicine without the need for an in-person examination. A temporary rule extended exemption through November 11, 2023.
May 22, 2023
This edition of Vital Signs is filled with digital health developments from around the world. In Industry Insights, you'll see and hear from Alexis Gilroy and Claire Castles...
May 16, 2023
DEA indicates along with SAMHSA that it will review comments received in response to the March 2023 Proposed Rules, conduct a thorough evaluation of regulatory alternatives, and issue one or more final rules based on the March 2023 Proposed Rules prior to 11 November 2023
May 13, 2023
DEA issued a temporary rule that extends pandemic-era flexibilities allowing prescribing of controlled substances based on a telehealth relationship through November 11, 2023. It remains to be seen how the DEA will address inclusion or exclusion of Schedule II controlled substances.